SC Filed 2019-01-31 Event — SEC 0001193125-19-023789 →

Novo Holdings A/S → Corvus Pharmaceuticals, Inc. CRVS

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -27.3%

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (14.9 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

36 filings by this filer

35 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 14.93

17,967,756 shares short · +1.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $22.14M

Point72 Asset Mgmt

Other 13D/G Filings on Corvus Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-27	SCHEDULE	ORBIMED ADVISORS LLC	10.30%	8,609,091	view →
2025-05-14	SCHEDULE	ORBIMED ADVISORS LLC	12.20%	9,785,423	view →
2021-11-03	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-09-22	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-08-04	SC	ORBIMED ADVISORS LLC	—	—	view →
2020-07-09	SC	Novo Holdings A/S	—	—	view →
2019-07-29	SC	Novo Holdings A/S	—	—	view →
2019-07-02	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-03-14	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Novo Holdings A/S

Filed	Form	Issuer	Stake	Shares
2026-07-31	SCHEDULE 13D/A	MAPLIGHT THERAPEUTICS, INC.	4.90%	2,086,622	view →
2026-01-23	SCHEDULE	IO Biotech, Inc. IOBTQ	3.30%	2,469,135	view →
2025-01-16	SCHEDULE	Galecto, Inc. DMRA	7.60%	99,913	view →
2024-03-18	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2024-01-02	SC	Rallybio Corp RLYB	—	—	view →
2023-08-11	SC	IO Biotech, Inc. IOBTQ	—	—	view →
2023-06-06	SC	LAVA Therapeutics NV	—	—	view →
2023-02-24	SC	LAVA Therapeutics NV	—	—	view →
2023-02-21	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2022-10-24	SC	Milestone Pharmaceuticals Inc. MIST	—	—	view →
2022-10-03	SC	LAVA Therapeutics NV	—	—	view →
2022-09-26	SC	Milestone Pharmaceuticals Inc. MIST	—	—	view →
2022-09-16	SC	Edgewise Therapeutics, Inc. EWTX	—	—	view →
2022-08-18	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →
2022-07-15	SC	Bolt Biotherapeutics, Inc. BOLT	—	—	view →
2022-02-22	SC	Morphic Holding, Inc.	—	—	view →
2022-01-27	SC	Reneo Pharmaceuticals, Inc. OKUR	—	—	view →
2021-12-20	SC	Cyteir Therapeutics, Inc.	—	—	view →
2021-11-22	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2021-11-22	SC	Bolt Biotherapeutics, Inc. BOLT	—	—	view →

Showing 20 of 35

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →